Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34832
Title: | Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis |
Authors: | Koca, Süleyman Serdar Öz, Burak Karataş, Ahmet Can, Gercek Şenel, Soner Yazıcı, Ayten İnanç, Nevsun Cefle, Ayşe Ertürk, Zeynep Akar, Servet Göker, Berna Birlik, Merih Önen, Fatoş Uludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı/Romatoloji Bilim Dalı. Dalkılıç, Ediz Pehlivan, Yavuz Yağız, Burcu AAG-8227-2021 |
Keywords: | Rheumatology |
Issue Date: | Jun-2018 |
Publisher: | BMJ |
Citation: | Koca, S. S. vd. (2018). ''Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 597-597. |
Description: | Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur. |
URI: | https://doi.org/10.1136/annrheumdis-2018-eular.5819 https://ard.bmj.com/content/77/Suppl_2/597.1 http://hdl.handle.net/11452/34832 |
ISSN: | 0003-4967 1468-2060 |
Appears in Collections: | Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Dalkılıç_vd_2018.pdf | 743.46 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License